CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Quince Therapeuticks Inc - QNCX CFD

    1.5486
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0328
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 1.5486
    Open* 1.4886
    1-Year Change* -75.76%
    Day's Range* 1.4886 - 1.5586
    52 wk Range 0.54-6.80
    Average Volume (10 days) 5.96M
    Average Volume (3 months) 47.40M
    Market Cap 56.59M
    P/E Ratio -100.00K
    Shares Outstanding 36.28M
    Revenue N/A
    EPS -1.61
    Dividend (Yield %) N/A
    Beta 1.38
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 31, 2023 1.5486 0.0600 4.03% 1.4886 1.5686 1.4886
    Mar 30, 2023 1.5486 0.0500 3.34% 1.4986 1.5686 1.4886
    Mar 29, 2023 1.5386 0.0499 3.35% 1.4887 1.5686 1.4687
    Mar 28, 2023 1.4687 0.0100 0.69% 1.4587 1.5186 1.4487
    Mar 27, 2023 1.4487 0.0200 1.40% 1.4287 1.5486 1.4287
    Mar 24, 2023 1.4587 0.0600 4.29% 1.3987 1.4787 1.3488
    Mar 23, 2023 1.3588 -0.0899 -6.21% 1.4487 1.4687 1.3488
    Mar 22, 2023 1.4187 0.0200 1.43% 1.3987 1.4687 1.3688
    Mar 21, 2023 1.4187 0.0000 0.00% 1.4187 1.5186 1.3388
    Mar 20, 2023 0.8196 0.0004 0.05% 0.8192 0.8360 0.7892
    Mar 17, 2023 0.8188 -0.0171 -2.05% 0.8359 0.8359 0.7848
    Mar 16, 2023 0.8193 -0.0066 -0.80% 0.8259 0.8557 0.7919
    Mar 15, 2023 0.8410 -0.0382 -4.34% 0.8792 0.8792 0.8155
    Mar 14, 2023 0.8716 -0.0339 -3.74% 0.9055 0.9155 0.8691
    Mar 13, 2023 0.8791 -0.0663 -7.01% 0.9454 0.9454 0.8656
    Mar 10, 2023 0.9237 -0.0326 -3.41% 0.9563 0.9752 0.9237
    Mar 9, 2023 0.9743 -0.0247 -2.47% 0.9990 1.0490 0.9643
    Mar 8, 2023 0.9832 0.0080 0.82% 0.9752 0.9950 0.9393
    Mar 7, 2023 0.9591 0.0079 0.83% 0.9512 0.9784 0.9491
    Mar 6, 2023 0.9667 0.0023 0.24% 0.9644 0.9868 0.9433

    Quince Therapeuticks Inc Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Total Operating Expense 52.015 90.318 78.893 39.168 12.119
    Selling/General/Admin. Expenses, Total 26.012 29.523 17.586 8.954 2.034
    Research & Development 25.178 60.795 61.307 30.214 10.085
    Operating Income -52.015 -90.318 -78.893 -39.168 -12.119
    Interest Income (Expense), Net Non-Operating 1.068 0.62 2.044 2.188 -0.357
    Net Income Before Taxes -51.944 -89.945 -76.849 -36.98 -12.476
    Net Income After Taxes -51.66 -89.945 -76.849 -36.98 -12.476
    Net Income Before Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
    Total Extraordinary Items
    Net Income -51.66 -89.945 -76.849 -36.98 -12.476
    Income Available to Common Excl. Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
    Income Available to Common Incl. Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
    Diluted Net Income -51.66 -89.945 -76.849 -36.98 -12.476
    Diluted Weighted Average Shares 33.4965 29.7185 29.1762 19.0319 26.0133
    Diluted EPS Excluding Extraordinary Items -1.54225 -3.02657 -2.63396 -1.94305 -0.4796
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -1.52624 -3.02657 -2.63396 -1.94305 -0.4796
    Other, Net -0.997 -0.247
    Unusual Expense (Income) 0.825
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 6.319 7.62 16.258 21.863 23.544
    Selling/General/Admin. Expenses, Total 3.551 4.344 9.059 9.106 8.331
    Research & Development 2.768 2.451 7.199 12.757 15.213
    Operating Income -6.319 -7.62 -16.258 -21.863 -23.544
    Interest Income (Expense), Net Non-Operating 0.536 0.315 0.145 0.072 0.105
    Net Income Before Taxes -5.534 -7.921 -16.848 -21.641 -23.399
    Net Income After Taxes -5.534 -7.921 -16.564 -21.641 -23.399
    Net Income Before Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
    Net Income -5.534 -7.921 -16.564 -21.641 -23.399
    Income Available to Common Excl. Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
    Income Available to Common Incl. Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
    Diluted Net Income -5.534 -7.921 -16.564 -21.641 -23.399
    Diluted Weighted Average Shares 35.7117 35.6128 32.467 30.1345 29.962
    Diluted EPS Excluding Extraordinary Items -0.15496 -0.22242 -0.51018 -0.71815 -0.78095
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -0.15496 -0.19925 -0.51018 -0.71815 -0.78095
    Other, Net 0.249 -0.616 -0.735 0.15 0.04
    Unusual Expense (Income) 0 0.825
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 111.673 137.862 106.056 72.584 7.537
    Cash and Short Term Investments 106.802 133.82 99.864 71.716 7.343
    Cash 40.27 35.69 4.074 11.259 7.343
    Cash & Equivalents 15.954 16.151 46.155 11.815 0
    Short Term Investments 50.578 81.979 49.635 48.642 0
    Prepaid Expenses 3.376 3.348 5.504 0.766 0.141
    Other Current Assets, Total 1.495 0.694 0.688 0.102 0.053
    Total Assets 133.228 189.466 124.37 72.877 7.718
    Property/Plant/Equipment, Total - Net 1.428 1.101 1.334 0.283 0.122
    Property/Plant/Equipment, Total - Gross 2.387 1.716 1.617 0.378 0.166
    Accumulated Depreciation, Total -0.959 -0.615 -0.283 -0.095 -0.044
    Other Long Term Assets, Total 0.194 0.039 0.217 0.01 0.059
    Total Current Liabilities 14.222 16.996 8.892 1.457 1.763
    Accounts Payable 4.911 3.555 3.075 0.495 0.517
    Accrued Expenses 9.311 13.441 5.817 0.962 1.246
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 14.642 17.204 8.892 1.457 10.82
    Total Long Term Debt 0 0 0 0 7.171
    Long Term Debt 0 7.171
    Other Liabilities, Total 0.42 0.208 0 1.886
    Total Equity 118.586 172.262 115.478 71.42 -3.102
    Redeemable Preferred Stock 0 104.046 17.178
    Common Stock 0.03 0.029 0.027 0.009 0.009
    Additional Paid-In Capital 355.234 318.574 185.196 0.239 0.06
    Retained Earnings (Accumulated Deficit) -236.599 -146.654 -69.805 -32.825 -20.349
    Other Equity, Total -0.079 0.313 0.06 -0.049 0
    Total Liabilities & Shareholders’ Equity 133.228 189.466 124.37 72.877 7.718
    Total Common Shares Outstanding 30.0744 29.5432 26.8694 26.0133 26.0133
    Long Term Investments 19.933 50.464 16.763
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 96.353 111.673 119.427 135.843 149.885
    Cash and Short Term Investments 91.524 106.802 114.412 129.95 147.035
    Cash 27.403 40.27 8.357 5.744 24.569
    Cash & Equivalents 32.361 15.954 36.6 47.049 38.246
    Short Term Investments 31.76 50.578 69.455 77.157 84.22
    Prepaid Expenses 2.784 3.376 4.52 5.455 2.293
    Other Current Assets, Total 2.045 1.495 0.495 0.438 0.557
    Total Assets 116.13 133.228 147.416 161.39 174.522
    Property/Plant/Equipment, Total - Net 0.573 1.428 1.655 1.886 0.878
    Property/Plant/Equipment, Total - Gross 1.569 2.387 2.53 2.674 1.579
    Accumulated Depreciation, Total -0.996 -0.959 -0.875 -0.788 -0.701
    Long Term Investments 19.175 19.933 26.141 23.516 23.72
    Other Long Term Assets, Total 0.029 0.194 0.193 0.145 0.039
    Total Current Liabilities 9.71 14.222 14.154 18.537 17.867
    Accounts Payable 3.731 4.911 2.88 7.193 2.845
    Accrued Expenses 5.979 9.311 11.274 11.344 15.022
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 9.75 14.642 14.764 19.31 18.038
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.04 0.42 0.61 0.773 0.171
    Total Equity 106.38 118.586 132.652 142.08 156.484
    Common Stock 0.03 0.03 0.03 0.03 0.029
    Additional Paid-In Capital 365.096 355.234 345.751 333.427 326.006
    Retained Earnings (Accumulated Deficit) -258.24 -236.599 -213.2 -191.494 -169.74
    Other Equity, Total -0.506 -0.079 0.071 0.117 0.189
    Total Liabilities & Shareholders’ Equity 116.13 133.228 147.416 161.39 174.522
    Total Common Shares Outstanding 30.1496 30.0744 29.8673 29.6558 29.5759
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -51.66 -89.945 -76.849 -36.98 -12.476
    Cash From Operating Activities -44.038 -62.932 -50.818 -33.277 -11.695
    Cash From Operating Activities 0.204 0.344 0.332 0.188 0.051
    Non-Cash Items 17.437 30.93 15.472 1.611 1.12
    Cash Interest Paid 0.001
    Changes in Working Capital -9.735 -4.261 10.227 1.904 -0.39
    Cash From Investing Activities 18.002 58.952 -52.431 -17.747 -46.754
    Capital Expenditures -0.133 -0.18 -0.052 -0.055 -0.212
    Other Investing Cash Flow Items, Total 18.135 59.132 -52.379 -17.692 -46.542
    Cash From Financing Activities 0.707 6.808 118.876 77.366 75.928
    Issuance (Retirement) of Stock, Net 0.756 6.808 118.91 77.925 75.678
    Issuance (Retirement) of Debt, Net -0.049 0 -0.034 -0.559 0.25
    Net Change in Cash -25.145 2.883 15.627 26.342 17.479
    Foreign Exchange Effects 0.184 0.055
    Deferred Taxes -0.284
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -51.66 -46.126 -38.205 -21.641 -89.945
    Cash From Operating Activities -44.038 -38.203 -31.506 -16.091 -62.932
    Cash From Operating Activities 0.204 0.162 0.122 0.038 0.344
    Non-Cash Items 17.437 16.03 14.565 9.375 30.93
    Changes in Working Capital -9.735 -7.985 -7.704 -3.863 -4.261
    Cash From Investing Activities 18.002 -0.664 8.162 13.413 58.952
    Capital Expenditures -0.133 -0.055 -0.005 -0.005 -0.18
    Other Investing Cash Flow Items, Total 18.135 -0.609 8.167 13.418 59.132
    Cash From Financing Activities 0.707 0.725 0.73 0.622 6.808
    Issuance (Retirement) of Stock, Net 0.756 0.756 0.742 0.622 6.808
    Net Change in Cash -25.145 -37.915 -22.796 -2.16 2.883
    Issuance (Retirement) of Debt, Net -0.049 -0.031 -0.012 0
    Foreign Exchange Effects 0.184 0.227 -0.182 -0.104 0.055
    Deferred Taxes -0.284 -0.284 -0.284
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Lamond (David A.) Individual Investor 10.1543 3683658 1634720 2022-01-31
    Dominy (Stephen S) Individual Investor 3.9631 1437674 763 2022-01-31
    Lynch (Casey C) Individual Investor 3.2544 1180580 -120000 2022-01-31
    EPIQ Capital Group, LLC Investment Advisor 2.9115 1056191 -1000478 2022-12-31 LOW
    Two Sigma Investments, LP Hedge Fund 2.4701 896084 -61145 2022-12-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.3524 853391 -18615 2022-12-31 LOW
    Pfizer Inc Corporation 1.6539 600000 -1456377 2021-12-31 MED
    Millennium Management LLC Hedge Fund 1.6424 595801 137810 2022-12-31 HIGH
    Low (Philip S) Individual Investor 1.2551 455309 455309 2022-05-19
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9169 332627 -165208 2022-12-31 LOW
    Thye (Dirk) Individual Investor 0.7744 280911 280911 2022-05-19
    Lowe (Christopher P) Individual Investor 0.7305 265000 175000 2022-03-03 LOW
    Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.6904 250458 -264583 2022-12-31 HIGH
    Smith (Karen L) Individual Investor 0.5367 194690 194690 2022-05-19 LOW
    Alphabet, Inc. Venture Capital 0.5213 189122 0 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.4248 154100 -180125 2022-12-31 HIGH
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.4239 153788 0 2022-12-31 MED
    Holsinger (Leslie) Individual Investor 0.3985 144580 -10920 2022-06-06
    Detke (Michael J) Individual Investor 0.3859 140000 140000 2022-03-03
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3779 137086 -9128 2022-12-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    269 East Grand Ave
    94080

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    BTC/USD

    28,401.90 Price
    -0.400% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda